Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Empire Manufacturing, Fed’s Williams speaks; 9:15ET Industrial Production, Capacity Utilization, Manufacturing Production; 9:45ET S&P Global US Manufacturing and Services PMIs TODAY’S HIGHLIGHTS: Detroit Pistons are on pace to be the worst NBA team of all timeGlobal coal use at all-time high
DARE-PTB1 is being developed as a treatment to reduce the risk of preterm birth, for which there are no FDA-approved treatment options Up to approximately $2 million in grant funding to support DARE-PTB1 Phase 1 human
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […]
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia, a symptom of VVA
Daré Bioscience Inc DARE announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option…